INS and Insulin resistance: T2D is characterized by insulin deficiency or insulin secretory defects, either with or without insulin resistance, and may be treated with oral medications, lifestyle, and dietary modifications; however, a large proportion of patients become insulin-dependent due to β-cell dysfunction.